-
Product Insights
Corneal Neovascularization Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The predisposing factors of Corneal Neovascularization include infections, trauma to the eye, chemical burns, immune system diseases, and certain other eye conditions, such as uveitis and glaucoma. Its symptoms are irritation in the eyes, dryness and pink eye or conjunctivitis, and light sensitivity. The Corneal Neovascularization pipeline market research report provides comprehensive information on the therapeutics under development for Corneal Neovascularization, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule...
-
Product Insights
Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Keratitis is an inflammation of the cornea. Symptoms include eye redness, eye pain, blurred vision, decreased vision, and sensitivity to light. The Keratitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for Keratitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news...
-
Product Insights
Leber Congenital Amaurosis (LCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leber Congenital Amaurosis (LCA) is the most common cause of inherited blindness in childhood. Its symptoms include vision loss, roving eye movements, deep-set eyes, developmental delay, epilepsy, and motor skill impairment. The Leber Congenital Amaurosis pipeline market research report provides comprehensive information on the therapeutics under development for Leber Congenital Amaurosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of...
-
Product Insights
Bacterial Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bacterial Conjunctivitis symptoms include redness in the white of the eye or inner eyelid, itchy eyes, blurred vision, increased sensitivity to light and burning eyes. Treatment includes antibiotics. The Bacterial Conjunctivitis pipeline drugs market research report provides an analysis of the Bacterial Conjunctivitis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Glaucoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Glaucoma signs and symptoms include eye pain, nausea and vomiting (accompanying the severe eye pain), sudden onset of visual disturbance, often in low light, blurred vision, and reddening of the eye. The Glaucoma pipeline drugs market research report provides an analysis of the Glaucoma drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and...
-
Product Insights
Keratoconjunctivitis sicca (Dry Eye) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Keratoconjunctivitis sicca (KCS) or dry eye disease (DED) or dry eye syndrome (DES) symptoms include hyperemia, mucoid discharge, ocular irritation, photophobia, and blurry vision. Risk factors include age, wearing contact lenses and low levels of vitamin A. Treatment includes artificial tear substitutes, topical anti-inflammatory agents, secretagogues, and immunosuppressants. The KCS pipeline drugs market research report provides an analysis of the KCS drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The...
-
Product Insights
Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Uveitis symptoms include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. Treatment includes steroid eye drops, anti-inflammatory, and antibiotic or antiviral medication. The Uveitis pipeline drugs market research report provides an analysis of the Uveitis drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history,...
-
Product Insights
Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Retinal Degeneration Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Retinal Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinal Degeneration, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Retinopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Retinopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Retinopathy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report...
-
Product Insights
Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Ocular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Ocular Inflammation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ocular Inflammation, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.